No serious adverse effects detected during Sputnik M trials, Health Ministry says.
Clinical trials of the Sputnik M vaccine against coronavirus for teens aged 12-17...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate...
The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...